Category: Stock Market

  • Costco misses on Q3 earnings estimates as coronavirus-related costs increase

    Costco misses on Q3 earnings estimates as coronavirus-related costs increaseOn Thursday, Costco reported third-quarter results that missed Wall Street expectations, although total comparable sales climbed 7.8%. Myles Udland breaks down the company’s quarterly report on The Final Round.

    from Yahoo Finance https://ift.tt/2AdDtvr

  • 5 Best Dividend Stocks to Buy in June

    from Yahoo Finance https://ift.tt/3doVq8Q

  • Wall Street Has Billions to Lose in China From Rising Strain

    Wall Street Has Billions to Lose in China From Rising Strain(Bloomberg) — Wall Street giants such as Goldman Sachs Group Inc. and JPMorgan Chase & Co. have tens of billions of dollars at stake in China as political tension risks derailing the nation’s opening of its $45 trillion financial market.Five big U.S. banks had a combined $70.8 billion of exposure to China in 2019, with JPMorgan alone plowing $19.2 billion into lending, trading and investing. That’s a 10% increase from 2018.While their assets in the country are comparatively small, they have big expansion plans there that may come undone if financial services firms are dragged into the tit-for-tat between the two countries. Not only would that cloud their growth plans, it would also threaten the income they have generated over the years from advising Chinese companies such as Alibaba Group Holding Ltd.Profits in China’s brokerage industry could hit $47 billion by 2026, Goldman estimates, with foreign firms gunning for a considerable chunk. There are $8 billion in estimated commercial banking profits as well as a projected $30 trillion in overall assets to go after, also being pursued by fund giants such as Blackrock Inc. and Vanguard Group Inc.“If you’re an American financial institution and you have an approved plan to expand into China, you’re going to continue that plan to the extent that the U.S. government allows you to because you see great future profits,” said James Stent, a former banker who’s spent more than a decade on the boards of two Chinese lenders. “A U.S.-China cold war is not good for your plans to build business in China.”After years of trade war turmoil, U.S. policy makers are now starting to take aim at the financial industry amid growing skepticism over American firms plowing money into a country perceived as a big geopolitical foe. Policy makers and lawmakers are looking at restricting U.S. pension fund investments in Chinese companies and limiting the ability of Chinese companies to raise capital in the U.S.A body advising the U.S. Congress this week questioned Wall Street’s push, saying lawmakers need to “evaluate the desirability of greater U.S. participation in a financial market that remains warped by the political priorities of a strategic competitor.” Add to that potential sanctions against China and even its banks over the crackdown on Hong Kong, and the situation could further escalate.President Donald Trump said he’s “not happy with China” after the country passed a new security law on Hong Kong and will announce new U.S. policies on Friday. His top economic adviser said Beijing would be held accountable by the U.S.Here’s a run down on the biggest U.S. banks’ presence in China right now and their plans.GoldmanGoldman, which has spent years lobbying for control of its onshore business, won approval this year. Chief Executive Officer David Solomon has pledged to infuse its mainland business with hundreds of millions of dollars in new capital as the bank plans to embark on a hiring spree to double its workforce to 600 and ramp up a wide variety of businesses.Goldman put its “cross-border outstandings” to China at $13.2 billion at the end of last year. But its two onshore operations had capital of just 1.8 billion yuan ($251 million), making a profit of almost 300 million yuan.A spokesman for Goldman declined to comment.Morgan StanleyHosting an annual summit in Beijing with 1,900 investors and 600 companies last year, Morgan Stanley Chief Executive Officer James Gorman said in a Bloomberg Television interview that the bank is in China “for the long run.” He highlighted its presence there for 25 years and its handling of hundreds of billions of dollars in equity and merger deals for Chinese businesses.Morgan Stanley won a nod to take majority control of its securities venture this year, and last year had a net exposure of $4.1 billion to Chinese clients. Its local securities unit, however, has revenue of just 132 million yuan, posting a loss of 109 million yuan last year.The bank has been overhauling senior management of the venture, installing its staff in key roles. It plans to apply for additional licenses to broaden its products and invest in new businesses, build market-making capability and expand its asset management partnership and ultimately take control.“It’s a natural evolution to bring the global investment banks into this market,” Gorman said in May last year.A Morgan Stanley spokesman declined to comment.JPMorganThe biggest U.S. bank has been doing business in China since 1921. Chief Executive Officer Jamie Dimon has said that his firm is committed to bringing its “full force” to the country. This year it applied for full control of an asset management firm as well as a securities venture, and is expanding its office space in China’s tallest skyscraper in downtown Shanghai.JPMorgan’s China total exposure in 2019 was $19.2 billion, including $11.3 billion in lending and deposits and $6.5 billion in trading and investing.JPMorgan China’s banking unit had 47 billion yuan in assets last year and made a profit of 276 million yuan, while its newly started securities firm had capital of 800 million yuan.A JPMorgan spokeswoman declined to comment.CitigroupCitigroup Inc., which has been doing business in China since 1902, had total exposure to the country of $18.7 billion at the end of last year. Its local banking arm had total assets of 178 billion yuan, making a profit of 2.1 billion yuan.Citigroup, which is setting up a new securities venture in China, is the only U.S. lender that has a consumer banking business in the country with footprint in 12 cities including Beijing, Changsha and Chengdu.New York-based Citigroup said last month that it has doubled its overall revenue from China to more than $1 billion over the past decade.China represents 1.1% of Citi’s total global exposure and includes local top tier corporate loans and loans to US and other global companies with operations in China, a bank spokesman said.Bank of AmericaBank of America Corp., the only major bank to decide against pursuing a securities joint venture, is continuing to expand into the world’s second-largest economy. The Charlotte, North Carolina-based lender is looking to provide a fuller range of fixed income services in the country.Its largest emerging market country exposure in 2019 was China, with net of $15.6 billion, concentrated in loans to large state-owned companies, subsidiaries of multinational corporations and commercial banks. It followed only the U.S., U.K., Germany, Canada and France in terms of exposure for the bank.A spokeswoman for the bank declined to comment.(Adds Trump comments in eighth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    from Yahoo Finance https://ift.tt/3eo6gfw

  • Why the Costa share price is sinking lower today

    man looking down falling line chart, falling share price

    The Costa Group Holdings Ltd (ASX: CGC) share price is on course to end the week in the red.

    The horticulture company’s shares are down over 3.5% to $3.18 in early trade.

    Why is the Costa share price dropping lower?

    Investors have been selling Costa’s shares following the release of its annual general meeting presentation this morning.

    After losing its chief financial officer earlier this month, today’s update reveals that another senior executive is on the way out. This time around it is Chief Executive Officer Harry Debney that is leaving.  

    According to the update, after over 10 years leading the company, Mr Debney plans to retire from the role within the next nine months. As such, the company and chief executive are currently in discussions regarding an orderly retirement transition plan. This includes looking internally an externally for a successor.

    What else did the company announce?

    After acknowledging that 2019 was a difficult year, management appears pleased with its performance year to date. Especially given the headwinds it faced early in the year.

    The company notes that the majority of its core produce categories are now experiencing positive demand and pricing from the retail sector. Furthermore, its farming operations are meeting yield and quality expectations.

    However, while there are no adverse effects from COVID-19 on its production, it notes that mitigation costs are considerable.

    These costs relate to an action plan the covers daily temperature testing, heightened hygiene protocols, and social distancing procedures. It has also had to deal with a fractured supply chain, from logistics through to ensuring it had an adequate labour force to meet its harvest needs.

    As a result, the company has no plans to reinstate any form of guidance for FY 2020 at this time. Which means investors may have to wait patiently until its results in August to see how the company is truly performing.

    Not sure about Costa right now? Then the five dirt cheap shares recommended below might be the ones to buy…

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended COSTA GRP FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why the Costa share price is sinking lower today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2TJhUKb

  • 3 dirt cheap ASX shares to buy before it is too late

    Man in white business shirt touches screen with happy smile symbol

    Although a number of shares have been hitting 52-week or record highs this week like Afterpay Ltd (ASX: APT), not all shares are trading close to these levels.

    A few top ASX shares are still trading at levels which I think make them cheap. Here’s why I would buy them:

    Aristocrat Leisure Limited (ASX: ALL)

    The Aristocrat Leisure share price is down 30% from its 52-week high. The catalyst for this decline has been the closure of casinos during the pandemic. As well as losing out on potential sales, the company was missing out on daily fees for its poker machines. The good news is that casinos are reopening and demand should soon pick up for its industry-leading machines. Another positive is that during the pandemic the company’s digital business has been booming. It now has 7.3 million daily active users playing its games which are generating significant recurring revenues.

    Sydney Airport Holdings Pty Ltd (ASX: SYD)

    The Sydney Airport share price has fallen 35% from its 52-week high. This has of course been driven by the collapse in tourism because of the pandemic. However, I feel this decline has been excessive and created a buying opportunity for patient investors. Especially with tourism markets likely to start recovering in the coming months. I expect domestic tourism to begin its recovery in the near future, with international tourism to follow in 2021. Based on this, I believe the company’s dividend could return to previous levels in 2022.

    Telstra Corporation Ltd (ASX: TLS)

    The Telstra share price is down 20% from its 52-week high, which I think is a buying opportunity for investors. This is because after years of struggles, the telco giant appears to be close to returning to growth. Especially given the early success of its T22 strategy, which is creating a much leaner operation. Combined with easing NBN headwinds and the arrival of 5G internet, I think Telstra could prove to be a great long term investment.

    And here are five dirt cheap ASX shares which analysts expect to rebound very strongly when the crisis passes…

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 dirt cheap ASX shares to buy before it is too late appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2M8Pt46

  • 2 ASX 200 tech shares I’d like to buy today

    Circuit board, Altium shares

    S&P/ASX 200 Index (ASX: XJO) tech stocks have been volatile in 2020, but it has been a mixed bag of performances. Not every ASX 200 tech share has performed as well as Afterpay Ltd (ASX: APT) this year, which means there are many still in the buy zone.

    Here are a couple of my top picks that are trading at a good price today.

    2 ASX 200 tech shares I’d like to buy today

    I think Xero Limited (ASX: XRO) shares are worth a look right now. The Xero share price has rocketed 343.86% higher in the last 5 years but has edged just 6.25% higher in 2020.

    Xero provides accounting software platform to small and medium-sized businesses and could see steady earnings despite the coronavirus pandemic.

    While some customers may not renew their subscriptions, I think the complexity arising from the JobKeeper stimulus package could be where Xero comes into its own. That’s good for earnings and the Xero share price.

    I also like the look of Altium Limited (ASX: ALU) shares right now.

    Altium provides electronics design software for engineers who design printed circuit boards. As the global economy emerges from hibernation, I think business could pick up again for this Aussie tech group.

    Altium shares are up 19.77% this year, which means its already a strong performer. However, it is currently trading at $37.02 per share (at the time of writing), compared to an all-time high of $42.76.

    I think Altium could be an ASX top 50 or even top 20 share within the next decade. With a $4.85 billion market capitalisation right now, Altium is well-placed to capitalise on the changing tech scene here in Australia.

    Foolish takeaway

    Both Altium and Xero are successful ASX 200 tech shares that have rocketed higher in recent years.

    However, I think a recovering economy and strong client base could be the key to boost both share prices even higher in 2020.

    For more companies to add to your watchlist, check out these 5 cheap ASX shares today!

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia owns shares of Altium. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 ASX 200 tech shares I’d like to buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2AgrLQH

  • Novavax (NVAX) Stock Is a Winner, but How Much Higher Can It Go?

    Novavax (NVAX) Stock Is a Winner, but How Much Higher Can It Go?Volatility is nothing new in the healthcare sector. Nonetheless, vaccine player Novavax’s (NVAX) recent spectacular moon bound rally is on another level.The stock surged by another 147% this month, cumulatively accruing 1025% of gains in 2020. Which begs the far-fetched question: Has Novavax provided the coveted vaccine? Not yet, but it is taking some big strides towards addressing the issue.The latest share appreciation came following news that the coalition for Epidemic Preparedness Innovations (CEPI) will commit up to $388 million to further the development of Novavax’ vaccine candidate against COVID-19 (SARS-CoV-2), NVX-CoV2373. The investment is CEPI’s biggest to date and follows on from what now feels like a miniscule initial $4 million grant to Novavax.In tandem with setting the process of clinical trials in motion (with Phase 1/2 trial data expected by July), part of the funding will go towards ramping up production at various locations around the globe, with a target of matching the largest pharma vaccine developers’ production capacity.Based on Novavax’ vaccine track record, Ladenburg Thalmann analyst Michael Higgins is confident in the outcome, and predicts the Phase 1/2 results “will prove to be safe.” The results are key to his thesis of Novavax’ rNPV (risk-adjusted net present value) as the data will have an impact on the “scale up activities.”Higgins expounded, “While CEPI and Novavax are working collectively to generate the manufacturing capabilities to reach one billion doses in 2021, we are modeling the 100M doses are sold in 2021 at $10/dose, with 50% net margins. Mgt has not provided guidance on our assumptions; but given the low net manufacturing costs (especially on a large scale) we believe our assumptions are within reasonable expectations. We believe the low manufacturing margins contributed to CEPI’s decision, as it seeks to partner with innovators to treat as many global citizens as possible.”Overall, Novavax gets 100% support from the Street, as all 5 analysts tracked over the last 3 months rate the vaccine player a Buy. With an average price target of $49.20, the analyst fraternity projects upside of nearly 10%. (See Novavax stock analysis on TipRanks)To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

    from Yahoo Finance https://ift.tt/36DWtPS

  • Why I think the CSL share price is a strong buy today

    Healthcare shares

    The CSL Limited (ASX: CSL) share price edged 0.17% lower yesterday to close at $287.51 per share. The Aussie biotech’s shares have climbed as high as $342.75 in 2020 before slumping in late May.

    Here are a few reasons why I think CSL could be a strong buy at its current price.

    Why the CSL share price could be a strong buy

    CSL is amongst the largest ASX 200 shares on the market with a $130.54 billion market cap. I think the CSL share price could be a buy, given large caps have tended to outperform small caps in past market downturns.

    The company is a leading healthcare player, which should help support CSL’s valuation in 2020. The Aussie company has a strong presence in both rare and serious diseases and influenza vaccines and antivenoms.

    Given its areas of specialisation, you may have expected the CSL share price to soar amid the coronavirus pandemic. However, CSL isn’t heavily involved in the race for a COVID-19 vaccination.

    That being said, the biotech giant has partnered with the University of Queensland in a COVID-19 vaccine development program. CSL is also investigating the role that immunoglobulin could play in terms of COVID-19 treatment here in Australia.

    I think much of CSL’s earnings will continue to hold up despite the pandemic. The Aussie healthcare group already reaffirmed its earnings guidance in April 2020.

    That alone doesn’t mean the CSL share price is in the buy zone. I think the key is to not overpay, even for high-quality ASX shares.

    At $287.51 per share, I think CSL is trading cheaply right now. Even in the midst of the recent bear market, CSL shares fell to just $270.88 on 20 March.

    The current price-to-earnings ratio of 42.55 times does look a touch high. However, I think the support around the current CSL share price level combined with a strong earnings profile is worth paying for in the current market. 

    If CSL isn’t in your buy basket right now, check out these 5 cheap ASX shares instead!

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why I think the CSL share price is a strong buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2XEVKd9

  • President Trump signs social media executive order

    President Trump signs social media executive orderPresident Donald Trump signed an executive order targeting social media companies. Yahoo Finance’s Alexis Keenan breaks down the details of the executive order on The Final Round.

    from Yahoo Finance https://ift.tt/3grPbmV

  • 10 quality ASX shares to buy in June

    Buy Shares

    A new month is on the horizon, so what better time to see if your portfolio could do with some new additions.

    Below I have picked out 10 quality ASX shares which I think have the potential to be market beaters in the coming years. Here’s why I would buy them in June:

    a2 Milk Company Ltd (ASX: A2M)

    I continue to believe that a2 Milk Company would be a great ASX share to own. This is largely down to the increasing demand for its infant formula in China and its relatively modest market share in the lucrative market.

    Altium Limited (ASX: ALU)

    Altium is an award-winning printed circuit board (PCB) design software provider. Over the last few years it has carved out a leading position in this growing market. Which is a big positive given the proliferation of electronic devices. This is likely to lead to increasing demand for its software over the next decade.

    Appen Ltd (ASX: APX)

    Another ASX share to consider is Appen. It is a leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI). Appen prepares or creates the data for the machine learning models of some of the largest tech companies such as Facebook and Microsoft. It also assisted in the creation of Apple’s Siri.

    Aristocrat Leisure Limited (ASX: ALL)

    This gaming technology company’s shares have fallen heavily this year due to the pandemic. The good news is that casinos are now starting to reopen, which should lead to a rebound in demand for its poker machines. In addition to this, its Digital business has been booming during lockdowns and is generating material recurring revenues.

    CSL Limited (ASX: CSL)

    I think this biotherapeutics giant could be a great long term option. I continue to believe CSL will be a market beater over the next decade. This is thanks to the increasing demand for immunoglobulins, its growing plasma collection network, and its pipeline of potentially lucrative products.

    Kogan.com Ltd (ASX: KGN)

    This ecommerce company’s shares have been on fire over the last couple of months thanks to a spike in sales and customer growth during the pandemic. Despite this, I would still be a buyer of its shares with a long term view. Especially given how the crisis appears to have accelerated the structural shift to online shopping.

    Megaport Ltd (ASX: MP1)

    Megaport is an elasticity connectivity and network services company. Its increasingly popular service allows users to increase and decrease their available bandwidth in response to their own demand requirements. This is instead of a user being tied to a fixed service level on long-term and expensive contracts. Demand for its service has been growing very strongly, leading to stellar recurring revenue growth.

    Nanosonics Ltd (ASX: NAN)

    Another ASX share to consider is Nanosonics. It is an infection control specialist which I believe has exceptionally strong growth potential. This is due to the sizeable market opportunity of its industry-leading trophon EPR disinfection system for ultrasound probes and the impending release of new products. These products are targeting other unmet needs in a market which infection control is becoming increasingly important.

    Pushpay Holdings Group Ltd (ASX: PPH)

    Pushpay is a fast-growing donor management platform provider for the faith and not-for-profit sectors. It has been growing its earnings at a rapid rate over the last couple of years and recently provided guidance for more strong growth in FY 2021. Looking further ahead, it is targeting a 50% share of the medium to large church market. This is a US$1 billion opportunity and many multiples of its current revenue.

    ResMed Inc. (ASX: RMD)

    A final ASX share to buy is ResMed. It is a medical device company with a focus on the sleep treatment market. I believe it is in a strong position for growth due to its industry-leading products and massive market opportunity. Management estimates that there are ~1 billion people suffering from sleep apnoea worldwide. However, only ~20% of these sufferers have been diagnosed.

    And if you still have space for more shares, these five recommendations below look like potential market beaters…

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd., MEGAPORT FPO, and Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Kogan.com ltd and PUSHPAY FPO NZX. The Motley Fool Australia owns shares of A2 Milk, Altium, and Appen Ltd. The Motley Fool Australia has recommended MEGAPORT FPO, Nanosonics Limited, and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 10 quality ASX shares to buy in June appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2BcQpSR